androgel
Chicago Judge overturns $140 million AbbVie AndroGel verdict
August 13, 2018Sales and Marketing AbbVie, Litigation, androgel, legal, testosterone
A US Judge has overturned a $140.1 million verdict against the New York-listed AbbVie Inc. The verdict, which ruled in …
AbbVie ordered to pay $448m over generic delays
July 2, 2018Sales and Marketing AbbVie, FTC, androgel, besins, branded generics, pharma
A US Judge has ordered pharmaceutical company AbbVie to pay $448 million after determining that the company had used sham …
Abbvie pays out over $3m after its testosterone replacement drug leads to heart attack
March 27, 2018Manufacturing and Production, Sales and Marketing AbbVie, Endo, GSK, androgel, heart attack, pharma
Abbvie has been ordered to pay over $3 million in damages to a man who asserts that the uise of …
AbbVie hit with $140m fine over fraudulent marketing of Androgel
October 6, 2017Medical Communications, Sales and Marketing AbbVie, androgel, biotech, drugs, pharma, pharmaceutical
AbbVie has been stung with a $140 million damages award to a man that suffered a heart attack after using …
Federal Trade Commission sues AbbVie and Teva
September 9, 2014Manufacturing and Production, Sales and Marketing AbbVie, FTC, Teva, androgel, federal trade commission
Authorities in the US claim that AbbVie and Teva filed ‘sham’ lawsuits in a complicated pay-to-delay case for generic forms …
Latest content
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
